Clinical Trials Browser

Phase 1/2 × INDUSTRY × Breakthrough Cancer Pain × Clear all

NCT04713189 2021-02-02

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain

Phase 1/2 Unknown

Breakthrough Cancer Pain